Your prediction
Novozymes A/S B Stock
The Novozymes A/S B stock is trending slightly upwards today, with an increase of €0.50 (0.880%) compared to yesterday's price.
Our community identified positive and negative aspects for Novozymes A/S B stock for the coming years. 1 users see the criterium "Return on equity" as a plus for the Novozymes A/S B stock. On the other hand our users think that "Revenue growth" could be a problem in the future.
Pros and Cons of Novozymes A/S B in the next few years
Pros
?
G***** c******* t* c**********
?
B****
?
C******** o* t** e**********
Cons
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Novozymes A/S B vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Novozymes A/S B | 0.880% | 2.125% | 12.354% | 19.404% | 15.806% | -3.482% | 33.164% |
Solvay S.A. A | -1.440% | -2.703% | 15.289% | -67.144% | 20.259% | -70.463% | -63.289% |
FMC Corp. | 0.580% | -4.218% | 13.147% | -40.782% | 2.393% | -39.322% | -11.946% |
Celanese Corp. A | -1.850% | -4.850% | -1.851% | 51.278% | 0.632% | 3.768% | 56.828% |